1-2 of 2
Stefano Ferrari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy

Caterina Mancarella, Michela Pasello, Selena Ventura, Andrea Grilli, Linda Calzolari, Lisa Toracchio, Pier-Luigi Lollini, Davide Maria Donati, Piero Picci, Stefano Ferrari, Katia Scotlandi
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3704–3716.
https://doi.org/10.1158/1078-0432.CCR-17-2602
Published: 31 July 2018
View articletitled, Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy
Open the PDF for Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy in another window
Includes: Supplementary data
Journal Articles

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models

Ymera Pignochino, Carmine Dell'Aglio, Marco Basiricò, Federica Capozzi, Marco Soster, Serena Marchiò, Stefania Bruno, Loretta Gammaitoni, Dario Sangiolo, Erica Torchiaro, Lorenzo D'Ambrosio, Franca Fagioli, Stefano Ferrari, Marco Alberghini, Piero Picci, Massimo Aglietta, Giovanni Grignani
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2117–2131.
https://doi.org/10.1158/1078-0432.CCR-12-2293
Published: 15 April 2013
View articletitled, The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
Open the PDF for The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models in another window
Includes: Supplementary data